Method of using humanized antibody against CD18
US5997867A · kind A · utility
108Cited by
11References
18Claims
0Family size
Inventors
Key dates
| Filing date | Jun 5, 1995 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Jun 5, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating patients suffering from, or at risk of developing, a leukocyte mediated disease comprising the administration of humanized antibodies and fragments thereof that bind human CD18 are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.